In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
Single-molecule analysis reveals the mechanism of transcription activation in M. tuberculosis
on May 23, 2018 at 11:26 am
1 Institut de Recherche en Infectiologie de Montpellier, CNRS, Université de Montpellier, Montpellier, France. 2 Centre de Biochimie Structurale, CNRS, INSERM, Université de Montpellier, Montpellier, France. The σ subunit of bacterial RNA polymerase ... […]
Fact check: Health minister quotes outdated WHO statistics on tuberculosis
on May 23, 2018 at 10:29 am
A claim made by the Minister of State for Health, Dr. Osagie Ehanire, on tuberculosis infection in Nigeria has been faulted by a nongovernmental organisation that holds public figures accountable. The NGO, Africa Check, in a release on Wednesday, quoted ... […]
A protein linking Parkinson's and tuberculosis could spur better drugs for both
on May 22, 2018 at 1:05 pm
A team of scientists has discovered that an immune mechanism that clears bacterial infections may also play a role in causing Parkinson's disease. The findings clarify the role of the protein LRRK2 in tuberculosis, suggesting that it behaves similarly in ... […]
Discovered Link Between Tuberculosis And Parkinson’s Disease
on May 22, 2018 at 8:37 am
The mechanism our immune cells use to clear bacterial infections like tuberculosis (TB) might also be implicated in Parkinson’s disease, according to a new collaborative study led by the Francis Crick Institute, Newcastle University and GSK. The findings ... […]
Advance genetics study identifies virulent strain of tuberculosis
on May 22, 2018 at 7:43 am
LSTM's Dr. Maxine Caws is co-lead investigator on an advanced genetics study published in Nature Genetics, which has shown that a virulent strain of tuberculosis (TB) has adapted to transmit among young adults in Ho Chi Minh City, Vietnam. The authors ... […]
Parkinson’s and Tuberculosis Linked through Immune Cell Mechanism
on May 22, 2018 at 7:30 am
Six degrees of separation is an early 20 th-century philosophy that all living things are inextricably linked in not such distant ways. While social media and network theory has added new life to the abstract concept in recent years, close connections in ... […]
Link between tuberculosis and Parkinson's disease discovered
on May 22, 2018 at 6:11 am
The mechanism our immune cells use to clear bacterial infections like tuberculosis (TB) might also be implicated in Parkinson's disease, according to a new collaborative study led by scientists from the Francis Crick Institute and Newcastle University. […]
How intestinal worms hinder tuberculosis vaccination
on May 22, 2018 at 5:13 am
New research in mice suggests that chronic infection with intestinal worms indirectly reduces the number of cells in lymph nodes near the skin, inhibiting the immune system's response to the Bacille Calmette-Guerin (BCG) vaccine for tuberculosis. […]
Bloomberg Opinion: Understanding the world's problem with tuberculosis
on May 22, 2018 at 5:06 am
Tuberculosis, a disease fueled by poverty, overcrowding and undernutrition, is a global barometer of deprivation. Of the more than 4,000 men, women and children TB kills every day, most are poor. TB’s connection to poverty is explained, in large part, by ... […]
What It Will Take to Finally Defeat Tuberculosis
on May 21, 2018 at 4:00 am
Tuberculosis has been around since before recorded history, yet humanity is still struggling to get the upper hand. In recent decades, some strains have developed resistance to the strongest antibiotics known to medicine. While the number of deaths ... […]
via Google News and Bing News